CN Patent

CN111683683A — Pde v抑制剂的液体口服制剂

Assigned to FTF Pharma Pvt Ltd · Expires 2020-09-18 · 6y expired

What this patent protects

本公开涉及包含PDE V抑制剂和一种或多种药物赋形剂或添加剂的药物组合物，其中所述药物组合物为液体药物组合物的形式。本公开的药物组合物用于治疗通过给药PDE V抑制剂药可治疗的疾病或病症，例如肺动脉高压、勃起功能障碍等。

USPTO Abstract

本公开涉及包含PDE V抑制剂和一种或多种药物赋形剂或添加剂的药物组合物，其中所述药物组合物为液体药物组合物的形式。本公开的药物组合物用于治疗通过给药PDE V抑制剂药可治疗的疾病或病症，例如肺动脉高压、勃起功能障碍等。

Drugs covered by this patent

Patent Metadata

Patent number
CN111683683A
Jurisdiction
CN
Classification
—
Expires
2020-09-18
Drug substance claim
No
Drug product claim
No
Assignee
FTF Pharma Pvt Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.